Cardiac PET perfusion tracers: Current status and future directions

Seminars in Nuclear Medicine

Volumn 44, Issue 5, 2014, Pages 333-343

  Maddahi, Jamshid ^a   Packard, René R S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

18F 4 FLLUOROPHENYLTRIPHENYLPHOSPHONIUM; 18F FLUOROBENZYLTRIPHENYLPHOSPHONIUM; 18F FLUORODIHYDROROTENONE; AMMONIA N 13; FLUORINE 18; FLURPIRIDAZ F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; THALLIUM 201; TRACER; UNCLASSIFIED DRUG; WATER O 15; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BODY DISTRIBUTION; CARDIAC IMAGING; CORONARY ARTERY DISEASE; CYCLOTRON; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; FEASIBILITY STUDY; HEART MUSCLE; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; ISOTOPE LABELING; MULTICENTER STUDY (TOPIC); MYOCARDIAL PERFUSION IMAGING; NONHUMAN; PHARMACOLOGIC STRESS TESTING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREADMILL TEST; ANIMAL; PROCEDURES;

ANIMALS; HUMANS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS;

EID: 84908041158     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2014.06.011     Document Type: Review

References (61)

1. V. Dilsizian, and R. Taillefer Journey in evolution of nuclear cardiology: Will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? JACC Cardiovasc Imaging 5 2012 1269 1284
2. C. Rischpler, M.J. Park, and G.S. Fung Advances in PET myocardial perfusion imaging: F-18 labeled tracers Ann Nucl Med 26 2012 1 6
3. S.G. Nekolla, and A. Saraste Novel F-18-labeled PET myocardial perfusion tracers: Bench to bedside Curr Cardiol Rep 13 2011 145 150
4. 15O Circulation 70 1984 724 733
5. E.V. Garcia, J.R. Galt, and T.L. Faber Principles of nuclear cardiology imaging Vasken Dilsizian Jagat Narula, Atlas of Nuclear Cardiology ed 4 2013 Springer Science 1 53
6. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres Circulation 87 1993 512 525
7. S.A. Kajander, E. Joutsiniemi, and M. Saraste Clinical value of absolute quantification of myocardial perfusion with (15)O-water in coronary artery disease Circ Cardiovasc Imaging 4 2011 678 684
8. 15O]water techniques Circulation 93 1996 2000 2006
9. T.H. Schindler, H.R. Schelbert, and A. Quercioli Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health JACC Cardiovasc Imaging 3 2010 623 640
10. 3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion Circulation 61 1980 34 43
11. H.R. Schelbert, M.E. Phelps, and S.C. Huang N-13 ammonia as an indicator of myocardial blood flow Circulation 63 1981 1259 1272
12. 3 myocardial extraction and clearance on flow and metabolism Am J Physiol 242 1982 H536 H542
13. 13N-ammonia at rest and during exercise Eur J Nucl Med Mol Imaging 11 1985 246 251
14. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography Circulation 80 1989 1328 1337
15. B.J. Chow, R.S. Beanlands, and A. Lee Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography J Am Coll Cardiol 47 2006 411 416
16. J. Czernin, P. Muller, and S. Chan Influence of age and hemodynamics on myocardial blood flow and flow reserve Circulation 88 1993 62 69
17. M. Di Carli, J. Czernin, and C.K. Hoh Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease Circulation 91 1995 1944 1951
18. T.H. Schindler, E.U. Nitzsche, and M. Olschewski Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors Circulation 110 2004 1069 1075
19. J.O. Prior, M.J. Quinones, and M. Hernandez-Pampaloni Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus Circulation 111 2005 2291 2298
20. T.H. Schindler, J. Cardenas, and J.O. Prior Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function J Am Coll Cardiol 47 2006 1188 1195
21. W.D. Love, and G.E. Burch A comparison of potassium 42, rubidium 86, and cesium 134 as tracers of potassium in the study of cation metabolism of human erythrocytes in vitro J Lab Clin Med 41 1953 351 362
22. W.D. Love, R.B. Romney, and G.E. Burch A comparison of the distribution of potassium and exchangeable rubidium in the organs of the dog, using rubidium Circ Res 2 1954 112 122
23. A.P. Selwyn, R.M. Allan, and A. L'Abbate Relation between regional myocardial uptake of rubidium-82 and perfusion: Absolute reduction of cation uptake in ischemia Am J Cardiol 50 1982 112 121
24. G. El Fakhri, A. Kardan, and A. Sitek Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: Comparison with (13)N-ammonia PET J Nucl Med 50 2009 1062 1071
25. M. Naya, V.L. Murthy, and V.R. Taqueti Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography J Nucl Med 55 2014 248 255
26. R.A. Goldstein, N.A. Mullani, and S.K. Marani Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions J Nucl Med 24 1983 907 915
27. 82Rb kinetics and a compartmental model for blood flow estimation Am J Physiol 256 1989 H1156 H1164
28. P. Herrero, J. Markham, and M.E. Shelton Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model Circulation 82 1990 1377 1386
29. 82Rb PET perfusion imaging J Nucl Med 52 2011 726 732
30. M.C. Ziadi, R.A. Dekemp, and K.A. Williams Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia J Am Coll Cardiol 58 2011 740 748
31. H. Farhad, V. Dunet, and K. Bachelard Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging Eur Heart J Cardiovasc Imaging 14 2013 1203 1210
32. V.L. Murthy, M. Naya, and C.R. Foster Improved cardiac risk assessment with noninvasive measures of coronary flow reserve Circulation 124 2011 2215 2224
33. 18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model J Nucl Med 53 2012 1779 1785
34. 18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging Nucl Med Biol 39 2012 1093 1098
35. 18F]-labeled (6-fluorohexyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography Bioconjug Chem 23 2012 431 437
36. 18F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography Bioorg Med Chem Lett 22 2012 319 322
37. P. Yalamanchili, E. Wexler, and M. Hayes Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: A novel PET myocardial imaging agent J Nucl Cardiol 14 2007 782 788
38. M. Yu, M.T. Guaraldi, and M. Mistry BMS-747158-02: A novel PET myocardial perfusion imaging agent J Nucl Cardiol 14 2007 789 798
39. 13N-ammonia and validation with microspheres in a pig model Circulation 119 2009 2333 2342
40. H.M. Sherif, A. Saraste, and E. Weidl Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats Circ Cardiovasc Imaging 2 2009 77 84
41. D.S. Berman, J. Maddahi, and B.K. Tamarappoo Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F 18 positron emission tomography J Am Coll Cardiol 61 2013 469 477
42. 18F-labeled myocardial perfusion tracer J Nucl Med 49 2008 630 636
43. J. Maddahi Properties of an ideal PET perfusion tracer: New PET tracer cases and data J Nucl Cardiol 19 2012 S30 S37
44. 18F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest J Nucl Med 52 2011 1490 1498
45. J. Maddahi, F. Bengel, and S.-C. Huang Phase 1 rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: Human safety, dosimetry, biodistribution, and myocardial imaging characteristics J Nucl Med 50 2009 184 ([abstract])
46. K.L. Gould, N.P. Johnson, and T.M. Bateman Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making J Am Coll Cardiol 62 2013 1639 1653
47. N.P. Johnson, and K.L. Gould Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity JACC Cardiovasc Imaging 5 2012 430 440
48. 13N-ammonia myocardial perfusion PET: Added value of myocardial flow reserve J Nucl Med 53 2012 1230 1234
49. R.A. Tio, A. Dabeshlim, and H.M. Siebelink Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease J Nucl Med 50 2009 214 219
50. 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve J Am Coll Cardiol 54 2009 150 156
51. R. Parkash, R.A. deKemp, and T.D. Ruddy Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease J Nucl Cardiol 11 2004 440 449
52. H.M. Sherif, S.G. Nekolla, and A. Saraste Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model J Nucl Med 52 2011 617 624
53. R.R.S. Packard, S-C Huang, and M. Dahlbom Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic F18 flurpiridaz positron emission tomography J Nucl Med 55 2014 1 7
54. A. Saraste, S. Kajander, and C. Han PET: Is myocardial flow quantification a clinical reality? J Nucl Cardiol 19 2012 1044 1059
55. 201Tl J Nucl Med 45 2004 1950 1959
56. 18F-fluorobenzyl triphenylphosphonium cation Eur J Nucl Med Mol Imaging 34 2007 2057 2065
57. 18F-fluorobenzyl triphenyl phosphonium in dog myocardium J Nucl Med 47 2006 1359 1366
58. 99mTc-tetrofosmin J Nucl Med 48 2007 1021 1030
59. 18F-fluorobenzyl triphenyl phosphonium after transient coronary occlusion J Nucl Med 52 2011 965 969
60. 18F-fluorobenzyl triphenyl phosphonium J Nucl Med 50 2009 774 780
61. 18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET Mol Imaging Biol 13 2011 511 517